<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medical Device Courses | Ahmed Elmonier | Mentions</title>
	<link>https://medicaldevicecourses.com/members/ahmed-elmonier/activity/mentions/</link>
	<atom:link href="https://medicaldevicecourses.com/members/ahmed-elmonier/activity/mentions/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed mentioning Ahmed Elmonier.</description>
	<lastBuildDate>Wed, 21 Oct 2026 01:01:56 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">74bab4c68dabfbb3d1ed9af2b845103e</guid>
				<title>aca replied to the topic  &#034;When Does a Surgeon Become a Brand Ambassador Ethically?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/59128/</link>
				<pubDate>Mon, 19 Oct 2026 00:10:40 -0400</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/ahmed-elmonier/' rel="nofollow ugc">@ahmed-elmonier</a> Disclosure of finances is important, but I don&#8217;t think it&#8217;s enough by itself. Even if the surgeon is completely honest about the financial relationship with a company, the relationship will always influence how they will view the medical device,&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/marketing-and-sales/when-does-a-surgeon-become-a-brand-ambassador-ethically/#post-24402" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">1ef5af8a36ab36da9655cb109e0be7da</guid>
				<title>dcapera replied to the topic  &#034;Can Product Claims Make Things More Complicated?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/58780/</link>
				<pubDate>Sun, 27 Sep 2026 23:46:27 -0400</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/ahmed-elmonier/' rel="nofollow ugc">@Ahmed-elmonier</a>, good point about claims changing the pathway. It connects to what we talked about with the 510(k) process. To get cleared, a new device has to be shown to be similar to a device already on the market, and&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/regulatory-basics-for-medical-devices/can-product-claims-make-things-more-complicated/#post-24195" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">77cb05c9978fce3d97014de4b8fa387c</guid>
				<title>aca replied to the topic  &#034;Regulatory Classification of Novel Devices&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/58776/</link>
				<pubDate>Sun, 27 Sep 2026 22:58:12 -0400</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/ahmed-elmonier/' rel="nofollow ugc">@ahmed-elmonier</a> The FDA should definitely consider the specific kinds of risks a potential new device can pose when deciding a new pathway. Certain risks can be easily detected and controlled compared to other risks. For instance, if there is a&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/regulatory-basics-for-medical-devices/regulatory-classification-of-novel-devices/#post-24192" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">c53c6deb2e3c8c86ad74189476db70d8</guid>
				<title>James Olson replied to the topic  &#034;From Pre-Clinical Research to Human Trials: When Is the Evidence Enough ?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/57969/</link>
				<pubDate>Sun, 20 Sep 2026 23:06:41 -0400</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/ahmed-elmonier/' rel="nofollow ugc">@ahmed-elmonier</a> I would definitely say the level of evidence needed before moving on should depend on the details of the condition. For example, if a new technology is being developed to potentially reduce the deterioration of a degenerative muscular disease,&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/pre-clinical-device-development/from-pre-clinical-research-to-human-trials-when-is-the-evidence-enough/#post-24096" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">cfcbacdd4bc737f0c627ed6ffd6d3557</guid>
				<title>James Olson replied to the topic  &#034;Deciding How to Perform Research in Industry&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/57963/</link>
				<pubDate>Sun, 20 Sep 2026 22:29:10 -0400</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/ahmed-elmonier/' rel="nofollow ugc">@ahmed-elmonier</a> I wouldn&#8217;t use an outside lab for industry for the reason you mentioned, the reduced control and monitoring over the lab. For projects to maintain consistent deadlines, adding a non-affiliated entity to the project has increased potential for miscommunication&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/pre-clinical-device-development/deciding-how-to-perform-research-in-industry/#post-24095" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">78adcadac078aeebd47673392382598a</guid>
				<title>enzo.1216 replied to the topic  &#034;Pressure vs. Safety: A Project Manager’s Toughest Decision&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/57353/</link>
				<pubDate>Mon, 14 Sep 2026 23:58:59 -0400</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/ahmed-elmonier/' rel="nofollow ugc">@ahmed-elmonier</a> I agree with your point that a safety concern does not always mean the entire project needs to stop because a safety concern does not necessarily affect every part of the project. I believe that the project manager should&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/intro-to-project-management/pressure-vs-safety-a-project-managers-toughest-decision/#post-24049" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>